Calcifediol

骨化二醇

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameCalcifediol
Drug Alias Name25-HydroxycholecalciferolCalcidiolCalcifediolum25-Hydroxyvitamin D3Rayaldy +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Cytokine Release SyndromeHyperparathyroidism, Secondary +[12] 
Global Approved IndicationsHyperparathyroidism, Secondary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOpko Health IncFAES Farma SAVifor Fresenius Medical Care Renal Pharma Ltd +[8] 
Inactive CompaniesDsm Nutritional Products IncOrganon Usa IncOpko Ip Holdings Ii Inc +[4] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Cytokine Release SyndromeHyperparathyroidism, Secondary +[8] 
Inactive IndicationsRenal Insufficiency, ChronicRenal InsufficiencyMalabsorption Syndromes +[4] 

Other Information

ATC CodeA11CC06
Related LinksWikipediaDrugBankKEGG